Literature DB >> 9552951

Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study.

P Maison1, B Balkau, D Simon, P Chanson, G Rosselin, E Eschwège.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9552951      PMCID： PMC28516          DOI： 10.1136/bmj.316.7138.1132

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984.

Authors:  B A Bengtsson; S Edén; I Ernest; A Odén; B Sjögren
Journal:  Acta Med Scand       Date:  1988

2.  Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica.

Authors:  G Rosselin; R Assan; R S Yalow; S A Berson
Journal:  Nature       Date:  1966-10-22       Impact factor: 49.962

Review 3.  Growth hormone and the heart.

Authors:  L Saccà; A Cittadini; S Fazio
Journal:  Endocr Rev       Date:  1994-10       Impact factor: 19.871

4.  Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status.

Authors:  B Balkau; E Eschwège; L Papoz; J L Richard; J R Claude; J M Warnet; P Ducimetière
Journal:  BMJ       Date:  1993-07-31

5.  Premature mortality due to cardiovascular disease in hypopituitarism.

Authors:  T Rosén; B A Bengtsson
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321
  5 in total
  10 in total

1.  Cardiovascular endocrinology: Growth hormone in CVD prediction--a tall order?

Authors:  Connie W Tsao; Ramachandran S Vasan
Journal:  Nat Rev Endocrinol       Date:  2014-11-18       Impact factor: 43.330

2.  Cerebral aneurysm and acromegaly: a case report.

Authors:  M C Zatelli; M Scanarini; M Bondanelli; M R Ambrosio; E C degli Uberti
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

3.  Growth hormone and aging.

Authors:  A Bartke; H Brown-Borg; B Kinney; J Mattison; C Wright; S Hauck; K Coschigano; J Kopchick
Journal:  J Am Aging Assoc       Date:  2000-10

4.  Echocardiographic assessment of subclinical left ventricular eccentric hypertrophy in adult-onset GHD patients by geometric remodeling: an observational case-control study.

Authors:  Cesare de Gregorio; Lorenzo Curtò; Antonino Recupero; Patrizia Grimaldi; Barbara Almoto; Marilena Venturino; Domenico Cento; Maria Carola Narbone; Francesco Trimarchi; Sebastiano Coglitore; Salvatore Cannavò
Journal:  BMC Endocr Disord       Date:  2006-02-28       Impact factor: 2.763

5.  Analysis of Low Frequency Protein Truncating Stop-Codon Variants and Fasting Concentration of Growth Hormone.

Authors:  Erik Hallengren; Peter Almgren; Gunnar Engström; Margaretha Persson; Olle Melander
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

6.  Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer study.

Authors:  Erik Hallengren; Peter Almgren; Gunnar Engström; Bo Hedblad; Margaretha Persson; Jennifer Suhr; Andreas Bergmann; Olle Melander
Journal:  J Am Coll Cardiol       Date:  2014-10-07       Impact factor: 24.094

Review 7.  Cancer risk following growth hormone use in childhood: implications for current practice.

Authors:  Amanda L Ogilvy-Stuart; Helena Gleeson
Journal:  Drug Saf       Date:  2004       Impact factor: 5.228

8.  Synchronous esthesioneuroblastoma and growth-hormone-secreting pituitary macroadenoma: combined open and endoscopic management.

Authors:  Costanza J Valdes; Marc A Tewfik; Marie-Christine Guiot; Salvatore Di Maio
Journal:  J Neurol Surg Rep       Date:  2014-07-21

9.  Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment.

Authors:  Erik Hallengren; Peter Almgren; Maria Rosvall; Gerd Östling; Margaretha Persson; Andreas Bergmann; Joachim Struck; Gunnar Engström; Bo Hedblad; Olle Melander
Journal:  BMC Cardiovasc Disord       Date:  2017-05-16       Impact factor: 2.298

10.  Genetic determinants of growth hormone and GH-related phenotypes.

Authors:  Erik Hallengren; Peter Almgren; Malin Svensson; Widet Gallo; Gunnar Engström; Margaretha Persson; Olle Melander
Journal:  BMC Genomics       Date:  2017-10-24       Impact factor: 3.969
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.